Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data ...
Biological engineers developed a computational approach to extracting useful information from large biological datasets. They showed they could unravel interactions that determine how the immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback